87 related articles for article (PubMed ID: 8173165)
1. Ovarian adenocarcinoma: prognostic evaluation after first laparotomy.
Villet R
Bull Cancer; 1993 Feb; 80(2):142-5. PubMed ID: 8173165
[TBL] [Abstract][Full Text] [Related]
2. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in stage I ovarian carcinoma.
Vergote I
Verh K Acad Geneeskd Belg; 2001; 63(3):257-71; discussion 272-6. PubMed ID: 11499346
[TBL] [Abstract][Full Text] [Related]
4. [Negative second-look laparatomy in ovarian cancers. Survival analysis and prognostic factors from 64 cases treated at the Gustave Roussy Institute].
Pautier P; Rey A; Michel G; Castaigne D; Rochard F; Duvillard P; Haie-Meder C; Curcio P; Benedetti-Richard L; Lhommé C
Bull Cancer; 1997 Feb; 84(2):147-54. PubMed ID: 9180837
[TBL] [Abstract][Full Text] [Related]
5. [Surgical strategy for peritoneal carcinosis of ovarian origin].
Michel G; Morice P; Castaigne D; Lanoux P
J Chir (Paris); 1997 Nov; 134(5-6):229-32. PubMed ID: 9772978
[TBL] [Abstract][Full Text] [Related]
6. [Construction and utilization of the prognostic model of serous ovarian adenocarcinoma].
Yang R; Feng J; Fang XZ; Bai F; Cheng YX; Liu C; Zhu W; Li L
Zhonghua Fu Chan Ke Za Zhi; 2006 Jul; 41(7):459-63. PubMed ID: 17083811
[TBL] [Abstract][Full Text] [Related]
7. [Staging and grading experiences in ovarian carcinoma and their prognostic value].
Bartl W; Janisch H; Szalay S; Szepesi T; Tatra G; Breitenecker G
Gynakol Rundsch; 1982; 22(2):158-64. PubMed ID: 6286427
[No Abstract] [Full Text] [Related]
8. [Assessment of prognostic factors in common ovarian tumors of varying malignancy].
Demeter A; Várkonyi T; Csapó Z; Szánthó A; Oláh J; Papp Z
Magy Onkol; 2004; 48(3):259-65. PubMed ID: 15520877
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of early normalization of CA 125 during chemotherapy in stages III and IV ovarian tumors].
Ferrero JM; Largillier R; Ramaioli A; Heudier P; Teissier E; Namer M
Bull Cancer; 1997 Jul; 84(7):722-8. PubMed ID: 9339198
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic factors in ovarian carcinoma].
Hauptmann S; Köbel M
Verh Dtsch Ges Pathol; 2005; 89():92-100. PubMed ID: 18035678
[TBL] [Abstract][Full Text] [Related]
11. Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor.
Kieback DG; McCamant SK; Press MF; Atkinson EN; Gallager HS; Edwards CL; Hajek RA; Jones LA
Cancer Res; 1993 Nov; 53(21):5188-92. PubMed ID: 8221656
[TBL] [Abstract][Full Text] [Related]
12. [Borderline ovarian tumors: an update].
Tulpin L; Rouzier R; Morel O; Malartic C; Daraï E; Barranger E
Gynecol Obstet Fertil; 2008 Apr; 36(4):422-9. PubMed ID: 18356093
[TBL] [Abstract][Full Text] [Related]
13. [Indications, standardization and therapeutic conclusions in second-look laparotomies in ovarian carcinoma].
Engeler V; Kunz J; Schreiner WE
Gynakol Rundsch; 1983; 23 Suppl 4():9-14. PubMed ID: 6674028
[No Abstract] [Full Text] [Related]
14. [Assessment of different histoprognosis grading systems for primary ovarian cancer: 100 patients given the same treatment for primary ovarian adenocarcinoma].
Penault-Llorca F; Levrel O; Clémenson A; Kwiatkowski F; Pomel C; Fouilhoux G; De Latour M; Curé H; Déchelotte P; Fonck Y; Dauplat J
J Gynecol Obstet Biol Reprod (Paris); 2000 Oct; 29(6):548-54. PubMed ID: 11084461
[TBL] [Abstract][Full Text] [Related]
15. [Comprehensive staging laparotomy in stage I epithelial ovarian cancer].
Shen K; Lang J; Lian L
Zhonghua Fu Chan Ke Za Zhi; 1996 Jul; 31(7):390-4. PubMed ID: 9275408
[TBL] [Abstract][Full Text] [Related]
16. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy.
Petit T; Velten M; d'Hombres A; Marchal C; Montbarbon X; Mornex F; Quetin P; Gérard JP; Romestaing P; Carrie C
Gynecol Oncol; 2007 Jan; 104(1):104-8. PubMed ID: 16987544
[TBL] [Abstract][Full Text] [Related]
19. Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages.
O'Brien ME; Schofield JB; Tan S; Fryatt I; Fisher C; Wiltshaw E
Gynecol Oncol; 1993 May; 49(2):250-4. PubMed ID: 8504995
[TBL] [Abstract][Full Text] [Related]
20. Is adjuvant radiotherapy in early stages (FIGO I-II) of epithelial ovarian cancer a treatment of the past?
Skirnisdottir I; Nordqvist S; Sorbe B
Oncol Rep; 2005 Aug; 14(2):521-9. PubMed ID: 16012740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
